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Purpose: The objective of this study is to examine heterogeneity among
clinical/symptomatic and radiographic osteoarthritis (COA/ROA) pheno-
types. The need for standardization of OA phenotypes in epidemiological
studies is addressed.
Methods: We collected descriptions of all OA phenotypes within the 28
studies involved in the TREAT-OA consortium. There are 18 cohort studies,
9 case-control studies and 1 randomized-controlled trial.
To discover if differences in OA deﬁnitions result in different association
results, we created all hip OA deﬁnitions used by studies of the consortium
in the Rotterdam Study-I. Association analyses were performed to study
the relationship between different OA deﬁnitions of the hip and age, gender
and (BMI) using one-way ANOVA.
After consensus was reached for the deﬁnition of knee and hip ROA, each
study standardized its ROA phenotype deﬁnitions and the prevalence of
ROA of the knee and hip was compared before and after standardization
for 6 cohort studies.
Results: A total of 54% (15/28) of studies deﬁned OA according to radio-
graphic features, while 46% (13/28) used a clinical or clinical + radiographic
OA deﬁnition. All studies with COA (n=11) used a different deﬁnition and/or
assessment of OA status for COA of the knee (n=10), hip (n=8) and hand
(n=2). For knee, hip and hand ROA, 5, 4 and 6 different ROA deﬁnitions
were used respectively.
When hip OA was deﬁned as one deﬁnite osteophyte, subjects with hip OA
were signiﬁcantly more frequent men compared to controls (P=2×10E10),
whilst total hip replacement cases were more frequent women compared
to controls (P=1×10E4). If ROA deﬁnitions are compared, we observed
that hip ROA deﬁned as deﬁnite JSN and one deﬁnite osteophyte was not
associated with BMI (p=0.94), whilst hip OA cases deﬁned as only one
deﬁnite osteophyte were associated with a slightly lower BMI (p=0.049).
After standardization, the prevalence of hip- and knee ROA was similar
in 6 cohort studies. Standardization of clinical OA phenotypes, although
desirable, was not possible due to the case-control study design of the
studies.
Conclusions: 1. Phenotype deﬁnitions do inﬂuence the outcomes in as-
sociation studies and therefore ROA phenotypes within the TREAT-OA
consortium were standardized to reduce heterogeneity. A standardized
ROA phenotype deﬁnition will improve the power in the anticipated
genetics studies.
2. Additional research is needed to reach a consensus for deﬁnitions of
clinical/symptomatic OA. We suggest that more thought should be given
to the establishment of clear guidelines for future research using clini-
cal/symptomatic OA cohorts, as this would have implications not just for
genetic studies, but also for the assessment of biomarkers, imaging and
interventional studies.
3. In the future, more precise OA phenotypes and stratiﬁcation according
to phenotypes should be mandatory for inclusion in large meta-analyses.
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Purpose: To identify the costs associated with knee OA in an elderly
Swedish population, from a societal perspective.
Methods: A questionnaire about knee pain was sent to 10,000 partici-
pants (age range 56-84 years) from the population-based Malmö Diet and
Cancer cohort (responders: 7,736). A random sample of 1,300 subjects
with chronic knee pain (duration of at least one month in the last year)
and a control group (650 subjects) were invited to a clinical examination
including x-ray of both knees (998 + 487 subjects underwent examination
and x-ray). Subjects who fulﬁlled ACR criteria and/or had radiographic knee
OA (ROA) were considered to have knee OA. The direct costs estimated
were hospitalizations, visits to nurse/GP, physiotherapist or knee specialist,
call to nurse/GP, and drugs, due to knee pain. The indirect costs estimated
were sick-leave and pre-retirement, due to knee pain.
Results: Approximately 20% (1,605/7,736) of the subjects had chronic
knee pain. Of those that participated in the examination and x-ray, 50%
(502/998) had knee OA. Among subjects with knee OA and chronic knee
pain; 39% had direct costs and 4% indirect costs, as compared to 20% and
1.6%, respectively, among subjects with chronic knee pain, but no knee OA,
and 3% and 0%, respectively, among control subjects. The mean total yearly
cost (direct + indirect) per subject with knee OA and chronic knee pain
was €1,715. The major contributor (71%) was indirect costs (sick-leave and
pre-retirement). The total costs for the subjects who fulﬁlled ACR criteria
were approximately 70% higher than for those who had ROA (€2,060 vs.
€1,189). Both females and males of age <65 years or age 65≥ with knee
OA and chronic knee pain had signiﬁcantly higher total costs than subjects
of the same sex and age group with chronic knee pain, but no knee OA.
Females of age <65 years with knee OA, or with chronic knee pain but no
knee OA, had signiﬁcantly higher total costs than females of age 65≥ in the
same diagnostic group. A similar signiﬁcant age dependence was not seen
in males.
Conclusions: A large proportion (50%) of the subjects with chronic knee
pain had knee OA. Total costs were markedly dependent on diagnostic
group, age and sex. The major contributor (71%) was indirect costs driven
by 4% of the subjects. If the prevalence rates and costs from this study
could be extrapolated to the general 56-84 year old population in Sweden,
this would correspond to approximately 260 000 Swedish individuals with
chronic knee pain and knee OA and a total annual cost of €560 millions.
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Purpose: To evaluate the inﬂuence of WOMAC total score on direct and in-
direct costs associated with chronic knee pain, with or without a diagnosis
for osteoarthritis, in an elderly Swedish population.
Methods: A random sample of subjects with self-assessed chronic knee
pain (duration for at least one month in the last year) was drawn from the
population-based Malmö Diet and Cancer cohort. After clinical examination,
including X-ray, subjects were divided into two diagnostic groups:
“OA” (n=502): Subjects with chronic knee pain fulﬁlling ACR criteria and/or
having a radiographic diagnosis of osteoarthritis.
“Pain” (n=496): Subjects with chronic knee pain but no diagnosis of
osteoarthritis.
For each subject, sex, age, body mass index (BMI) and WOMAC total score
were assessed, and the total yearly costs per patient estimated. Total
costs included direct costs (hospitalizations, visits to GP/knee specialist/
nurse/physiotherapist and medications due to knee pain) and indirect costs
(sick-leave and pre-retirement). The quantitative inﬂuence on total costs
from the WOMAC total score, and from the demographic variables, was
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studied using a “2-part model”, where the probability of non-zero total
costs is modelled by logistic regression, and the mean level of the logarithm
of non-zero total costs by a general linear model (GLM). The diagnostic
group was a factor in both models, and the potential predictors including
WOMAC total score, sex, age and BMI were integrated as covariates.
Results: Of the 998 subjects included, 331 were male and 667 females.
Age ranged from 56 to 84 (mean 69.2) years, BMI from 14.4 to 56.0 (mean
28.1) kg/m2, and WOMAC total score from 0 to 94 (mean 31.3) units. Based
on the 2-part model, the probability of non-zero total costs was 0.406
in the OA group and 0.210 in the pain group. WOMAC total score, as a
continous variable, was a statistically signiﬁcant (p<0.0001) predictor of
the probability for non-zero total costs, and also a statistically signiﬁcant
predictor (p=0.0082) of the mean level of non-zero total costs (€4,955 “OA”
and €2,819 for “pain” group). An increase in WOMAC total score of 30 units
was estimated to correspond to an odds ratio of 2.05 (95% CI 1.62 to 2.61)
regarding the probability of non-zero total costs, and a multiplier of 1.52
(95% CI 1.12 to 2.07) regarding the mean level of non-zero total costs. Age
65≥ was associated with statistically signiﬁcantly (p<0.001) lower mean
non-zero total costs, compared with age <65 years (multiplier = 0.42).
An explanation for this is that pre-retirements costs, which are likely to
constitute a very large part of total costs, only occur at age <65 years.
Conclusions: The mean total costs increased signiﬁcantly with the WOMAC
total score, as do the probability of reporting non-zero total costs and the
mean non-zero total costs, both of which are constituent factors of the
mean total costs. Higher disease activity, as reﬂected by higher WOMAC
score, correlates with higher costs.
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CAN WE EXPLAIN THE DRAMATIC INCREASE IN TKR UTILIZATION RATES
IN US BY POPULATION SIZE AND OBESITY EPIDEMIC GROWTH?
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Purpose: Utilization of total knee replacement doubled over the decade be-
tween 1997 and 2007. Several published studies attributed these increases
to the growing population and the obesity epidemic, although the most
recent published data suggest the proportion of obese Americans increased
by < 15% between 1997 and 2007. We sought to investigate whether TKR
rate increases were disproportionally higher in younger compared to older
age groups.
Methods: We used data from National Inpatient Sample (NIS), the largest
all-payer inpatient care database in the United States, containing data from
approximately 8 million hospital stays each year. NIS data are designed to
examine trends in utilization of speciﬁc procedures over time. We coupled
the NIS-based data with population size estimates from US Census data to
estimate changes in TKR utilization rates over the decade from 1997 to
2007 stratiﬁed by age groups (18-44, 45-64, 65-84, 85+). We estimated the
proportion of TKRs performed in each age group across ten year period and
compared rate of change in TKR utilization with changes in population size
from 1997 to 2007.
Results: In 2007 550,161 total knee replacements were performed in the
US, 100% more than were performed in 1997. During the same time period
the overall population size increased by just 15%. While the population of
45-64 year olds grew by 38%, the number of TKRs done in this age group
more than tripled (Figure 1). The largest increase in population over the
decade (41%) was observed in 85+ age group. The corresponding increase
in TKR utilization in this age group reached 70%. Across all age groups
the increase in TKR rates was substantially higher than corresponding
increase in population size, but relative difference between the growth in
population and utilization of TKR was highest in 44-65 age group. TKRs in
the younger age group 45-64 increased from 25% of all TKRs performed in
1997 to 40% in 2007. In contrast, in 1997 69% of all TKRs were done in
persons 65-84 years of age compared to only 55% of all TKRs done in the
2007. The proportion of TKRs performed in oldest age group 85+ years of
age decreased slightly from 3.5% in 1997 to 2.9% in 2007. Examination of
population size trends and trends in the obesity epidemic suggested that
only about 20% of increases in utilization of TKRs could be explained by
population and obesity growth.
Conclusions: The absolute number of TKRs increased in all age groups dur-
ing the decade from 1997 to 2007. As a proportion of all TKRs performed
in a particular year, the proportion performed in younger age groups
increased and proportion of TKRs done in older persons decreased over the
ten year period. These data suggest that expanding the indications for TKR
Figure 1
in younger ages is the likely explanation for the dramatic increase in TKR
rates in US.
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AFRICAN-AMERICAN ANDWHITE DIFFERENCES IN KNEE PAIN AND
ARTHRITIS IMPAIRMENT: A POPULATION-BASED STUDY
S. Morewitz
California State Univ., East Bay, San francisco, CA
Purpose: Studies suggest that some minority groups, especially African-
Americans with osteoarthritis, may be at risk for higher rates of lower
extremity pain and disability compared to Caucasian Americans. In addi-
tion, African-Americans are less likely to undergo arthroplasty compared to
Caucasian Americans. However, more research needs to be done to assess
possible differences in lower extremity pain and arthritis impairment
among minorities and Caucasian Americans.
Methods: The following study tests the null hypothesis that the association
between right knee pain and arthritis impairment does not differ between
African-Americans and Caucasian Americans, after adjusting for other pos-
sible predictor variables, such as gender, age, and household income. The
ﬁndings from the population-based 1998 National Health Interview Survey
(N=30,534 adults) were used. Descriptive and correlational procedures
evaluated possible Black/White differences in the association between right
knee pain and arthritis impairment related to walking ¼ of a mile without
special equipment.
Results: The null hypothesis was mostly rejected. The association between
right knee pain and arthritis impairment was higher among African-
Americans (r=+0.206, N=466, p<0.000) than among whites (r=+0.127,
N=2,579, p<0.000). These results remained signiﬁcant after adjusting for
possible intervening variables.
Conclusions: These ﬁndings highlight the need to screen for and ag-
gressively manage knee pain and arthritis impairment, especially among
African-Americans.
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Purpose: To know Knee OA prevalence in young patients with anterior
cruciate ligament (ACL) injury and evaluate risk factor for OA severity.
Methods: A retrospective and descriptive study. Inclusion criteria, patients
with anterior cruciate ligament injury who underwent to arthroscopic
ACL repair. OA was documented at surgery moment by the surgeons.
We recollect variables as risk factor in development knee OA in young
patents: presence of meniscal lesion, gender, age, weight, evolution time,
mechanism of injury. Statistical analysis was done with STATA software®.
A descriptive analysis, bivariated analysis was realized with appropriated
parametric statistical test.
